143 related articles for article (PubMed ID: 25405734)
1. WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.
Chen J; Yin J; Li X; Wang Y; Zheng Y; Qian C; Xiao L; Zou T; Wang Z; Liu J; Zhang W; Zhou H; Liu Z
Int J Mol Sci; 2014 Nov; 15(11):21011-27. PubMed ID: 25405734
[TBL] [Abstract][Full Text] [Related]
2. Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.
Chen J; Yin JY; Li XP; Wang Y; Zheng Y; Qian CY; He H; Fang C; Wang Z; Zhang Y; Xiao L; Wang SY; Zhang W; Zhou HH; Liu ZQ
Clin Lung Cancer; 2015 Jul; 16(4):298-304.e1-2. PubMed ID: 25656821
[TBL] [Abstract][Full Text] [Related]
3. The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy.
He J; Wang Z; Wang Y; Zou T; Li XP; Cao L; Chen J
Pharmgenomics Pers Med; 2021; 14():1193-1203. PubMed ID: 34566424
[TBL] [Abstract][Full Text] [Related]
4. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.
Lau HK; Wu ER; Chen MK; Hsieh MJ; Yang SF; Wang LY; Chou YE
PLoS One; 2017; 12(4):e0176246. PubMed ID: 28426731
[TBL] [Abstract][Full Text] [Related]
6. Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.
Chen CT; Lee HL; Chiou HL; Chou CH; Wang PH; Yang SF; Chou YE
PLoS One; 2018; 13(6):e0198967. PubMed ID: 29889892
[TBL] [Abstract][Full Text] [Related]
7. Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients.
Liu JY; Qian CY; Gao YF; Chen J; Zhou HH; Yin JY
Chin J Cancer; 2017 Jan; 36(1):12. PubMed ID: 28093084
[TBL] [Abstract][Full Text] [Related]
8. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
[TBL] [Abstract][Full Text] [Related]
9. Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity.
Chen J; Wu L; Wang Y; Yin J; Li X; Wang Z; Li H; Zou T; Qian C; Li C; Zhang W; Zhou H; Liu Z
Tumour Biol; 2016 Feb; 37(2):2275-84. PubMed ID: 26358256
[TBL] [Abstract][Full Text] [Related]
10. Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.
Lin YH; Hsiao YH; Yang SF; Liu YF; Hsu CF; Wang PH
Reprod Sci; 2018 Nov; 25(11):1549-1556. PubMed ID: 29402200
[TBL] [Abstract][Full Text] [Related]
11. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity.
Hu L; Chen SH; Lv QL; Sun B; Qu Q; Qin CZ; Fan L; Guo Y; Cheng L; Zhou HH
Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27249003
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.
Zou T; Yin J; Zheng W; Xiao L; Tan L; Chen J; Wang Y; Li X; Qian C; Cui J; Zhang W; Zhou H; Liu Z
Cancer Chemother Pharmacol; 2016 Aug; 78(2):249-58. PubMed ID: 27299748
[TBL] [Abstract][Full Text] [Related]
14. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
Gong WJ; Yin JY; Li XP; Fang C; Xiao D; Zhang W; Zhou HH; Li X; Liu ZQ
Tumour Biol; 2016 Jun; 37(6):8349-58. PubMed ID: 26729200
[TBL] [Abstract][Full Text] [Related]
15. Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.
Johnson C; Pankratz VS; Velazquez AI; Aakre JA; Loprinzi CL; Staff NP; Windebank AJ; Yang P
J Neurol Sci; 2015 Feb; 349(1-2):124-8. PubMed ID: 25586538
[TBL] [Abstract][Full Text] [Related]
16. Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy.
Fang C; Li XP; Gong WJ; Wu NY; Tang J; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():21-29. PubMed ID: 27873337
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.
Qian J; Liu H; Gu S; Wu Q; Zhao X; Wu W; Wang H; Wang J; Chen H; Zhang W; Wei Q; Jin L; Lu D
Clin Lung Cancer; 2015 Sep; 16(5):e37-53. PubMed ID: 25818095
[TBL] [Abstract][Full Text] [Related]
18. Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Cui JJ; Wang LY; Zhu T; Gong WJ; Zhou HH; Liu ZQ; Yin JY
Sci Rep; 2017 Jul; 7(1):5082. PubMed ID: 28698656
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
20. The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.
Powrózek T; Mlak R; Krawczyk P; Homa I; Ciesielka M; Kozioł P; Prendecka M; Milanowski J; Małecka-Massalska T
Clin Transl Oncol; 2016 Feb; 18(2):125-31. PubMed ID: 26193985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]